Literature DB >> 19667341

Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.

Victor M Elner1, Paula Anne Newman-Casey, A Jayaprakash Patil, Andrew Flint, Jyotirmay Biswas, Sayoko E Moroi, Vaijayanthi Pushparaj, Deepak P Edward.   

Abstract

OBJECTIVE: To characterize histopathologic features of leaking mitomycin C-treated blebs and aberrant wound healing that may lead to persistent conjunctival thinning and leakage.
METHODS: Forty mitomycin C-treated filtering blebs excised for persistent leaks from 40 patients were examined histopathologically using hematoxylin-eosin, periodic acid-Schiff, Masson trichrome, and Alcian blue histochemical stains.
RESULTS: Ninety percent of the leaking blebs contained epithelial-stromal domes with areas of acellular stroma covered by attenuated epithelium. Seventy-five percent of the blebs demonstrated varying degrees of fibrovascular repair growing from the bleb margin, either beneath or interdigitating with the acellular zone. A novel observation in 65% of specimens was Alcian blue-positive myxoid stroma at the interface between the fibrovascular proliferation and the epithelial-stromal dome. The association between the presence of fibrovascular proliferation and Alcian blue-staining myxoid stroma was significant by Fisher exact test (P = .002).
CONCLUSIONS: A desirable filtration bleb requires a sufficient reparative fibrovascular response to maintain an epithelial-stromal barrier to prevent leakage. Fibroblasts must lay down a continuous collagen-rich fibrous layer, rather than merely myxoid stroma, beneath the conjunctival epithelium to promote bleb stability. Surgical techniques and postsurgical care should aim to attain this desired outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667341      PMCID: PMC4110904          DOI: 10.1001/archophthalmol.2009.161

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  30 in total

Review 1.  Wound healing modulation in glaucoma filtering surgery.

Authors:  Sean-Paul A Atreides; Gregory L Skuta; Adam C Reynolds
Journal:  Int Ophthalmol Clin       Date:  2004

2.  The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits.

Authors:  T J Bergstrom; W S Wilkinson; G L Skuta; R L Watnick; V M Elner
Journal:  Arch Ophthalmol       Date:  1991-12

Review 3.  Correlation of filtration bleb morphology with histology.

Authors:  Theodoros Filippopoulos; Eissa Hanna; Teresa C Chen; Cynthia L Grosskreutz; Frederick A Jakobiec; Louis R Pasquale
Journal:  Int Ophthalmol Clin       Date:  2009

Review 4.  The fibroblast and wound repair.

Authors:  R Ross
Journal:  Biol Rev Camb Philos Soc       Date:  1968-02

Review 5.  The tensile strength of wounds and factors that influence it.

Authors:  W Van Winkle
Journal:  Surg Gynecol Obstet       Date:  1969-10

6.  Histologic characteristics of filtering blebs in glaucomatous eyes.

Authors:  E M Addicks; H A Quigley; W R Green; A L Robin
Journal:  Arch Ophthalmol       Date:  1983-05

Review 7.  Wound healing in glaucoma filtering surgery.

Authors:  G L Skuta; R K Parrish
Journal:  Surv Ophthalmol       Date:  1987 Nov-Dec       Impact factor: 6.048

8.  Conjunctival dysfunction and mitomycin C-induced hypotony.

Authors:  R Sihota; T Dada; S D Gupta; S Sharma; R Arora; H C Agarwal
Journal:  J Glaucoma       Date:  2000-10       Impact factor: 2.503

9.  Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation.

Authors:  Anthony C B Molteno; Martin Fucik; Alex G Dempster; Tui H Bevin
Journal:  Ophthalmology       Date:  2003-11       Impact factor: 12.079

10.  Clinical and anatomical reversal of long-term hypotony maculopathy.

Authors:  John O Oyakhire; Sayoko E Moroi
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more
  1 in total

1.  Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model.

Authors:  Yuji Yamamoto; Atsushi Mukai; Toru Ikushima; Yasuo Urata; Shigeru Kinoshita; Junji Hamuro; Morio Ueno; Chie Sotozono
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.